arrow
A

Aekta Shah

pathology
H指数:10
被引数:385

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

H3K27M-altered diffuse midline glioma: experience and outcomes from a low-Middle income country (LMIC) setting in the contemporary era

中线弥漫性胶质瘤H3K27M突变:当代时代低中等收入国家(LMIC)环境中的经验与结果

2026-05-040
OA
Study protocol of memantine to preserve memory and neurocognition following craniospinal irradiation: a phase 3 randomized controlled trial (MEMENTO)

美金刚维持颅脑脊髓照射后记忆和神经认知功能的研究方案:一项3期随机对照试验(MEMENTO)

2026-02-110
OAAI
Incidence of seizures and practice patterns of antiseizure medications in primary supratentorial brain tumors: results from a prospective study

癫痫发作的发生率及抗癫痫药物的使用模式:来自一项前瞻性研究的结果

2025-11-010
OAAI
Does the Extent of Resection matter In Medulloblastomas? In an era of Molecular Subgrouping: A single-center Indian study

髓母细胞瘤的切除范围是否重要?——分子亚组分型时代的单中心印度研究

2025-11-010
OAAI
OUTCOMES OF SOLITARY FIBROUS TUMOURS OF CNS (SOFT)

中枢神经系统孤立性纤维瘤(SOFT)的结局

2025-11-010
PRE
Peri-operative Outcomes Following Primary Surgery For Medulloblastomas And Association With Molecular Subgroups

髓母细胞瘤初次手术后的围手术期结果及其与分子亚组的关系

2025-11-010
OAAI
Study protocol of short versus long-term levetiracetam in brain tumors (LIBRA): a phase 3 randomized controlled trial

短程与长程左乙拉西坦在脑肿瘤中的研究方案(LIBRA):一项Ⅲ期随机对照试验

2025-05-210
OA
Docetaxel-oxaliplatin-capecitabine/5-fluorouracil (DOX/F) followed by docetaxel versus oxaliplatin-capecitabine/5-fluorouracil (CAPOX/FOLFOX) in HER2-negative advanced gastric cancers
2024-07-272
OAAI